Prescription Drug Event Record Reporting Instructions for the Implementation of the Inflation Reduction Act for Contract Year 2025

Relevant to: All Part D Sponsors

The purpose of this memorandum is to present the Prescription Drug Event (PDE) record reporting instructions effective January 1, 2025, consistent with the provisions of the Inflation Reduction Act of 2022 (IRA) (P.L. 117-169), that are effective January 1, 2025 in the Part D program. Specifically, this document provides PDE examples for contract year (CY) 2025 and should not be used for prior benefit years. For prior benefit years, Part D plan sponsors should refer to previous guidance and examples released by the Centers for Medicare & Medicaid Services (CMS).

See the full guidance for more information.